OpenAlex Citation Counts

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Blazing a trail for the clinical use of rapamycin as a geroprotecTOR
Adam R. Konopka, Dudley W. Lamming, Brittany A. Grasso, et al.
GeroScience (2023) Vol. 45, Iss. 5, pp. 2769-2783
Open Access | Times Cited: 15

Showing 15 citing articles:

Trends in Drug Repurposing: Advancing Cardiovascular Disease Management in Geriatric Populations
Murali Krishna Moka, Melvin George, Deepalaxmi Rathakrishnan, et al.
Current Research in Translational Medicine (2025) Vol. 73, Iss. 2, pp. 103496-103496
Closed Access | Times Cited: 1

The bioavailability and blood levels of low-dose rapamycin for longevity in real-world cohorts of normative aging individuals
Girish Harinath, Virginia Lee, Andy Nyquist, et al.
GeroScience (2025)
Open Access | Times Cited: 1

Mikhail ‘Misha’ Blagosklonny’s enduring legacy in geroscience: the hyperfunction theory and the therapeutic potential of rapamycin
David Barzilai
Aging (2025)
Open Access

Elevated Levels of Plasma Phosphorylated Tau 181 (pTau181) Associated With Opioid Use to Guide Medication Titration Over a Clinically Relevant Short Timescale
Emily Hanson, Karl Berner, Jon Berner
Cureus (2025)
Open Access

Molecular mechanism on autophagy associated cardiovascular dysfunction in Drosophila melanogaster
Wei Zhan, Rong Zhou, Xinjuan Lei, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access

Rapamycin does not compromise physical performance or muscle hypertrophy after PoWeR while intermittent rapamycin alleviates glucose disruptions by frequent rapamycin
Christian Elliehausen, Szczepan S. Olszewski, Carolyn G. Shult, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access

Natural Products in Aging: Cellular Mechanisms and Emerging Therapeutics for Age‐Related Disorders
Versha Dixit, Kundan Kumar Chaubey, Deen Dayal, et al.
Journal of Aging Research (2025) Vol. 2025, Iss. 1
Open Access

Influence of rapamycin on safety and healthspan metrics after one year: PEARL trial results
Mauricio Moel, Girish Harinath, Virginia Lee, et al.
Aging (2025)
Open Access

The role of quality of life data as an endpoint for collecting real-world evidence within geroscience clinical trials
Girish Harinath, Sajad Zalzala, Andy Nyquist, et al.
Ageing Research Reviews (2024) Vol. 97, pp. 102293-102293
Open Access | Times Cited: 3

Towards Healthy Longevity: Comprehensive Insights from Molecular Targets and Biomarkers to Biological Clocks
Khalishah Yusri, Sanjay Kumar, Sheng Fong, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6793-6793
Open Access | Times Cited: 3

Safety and efficacy of rapamycin on healthspan metrics after one year: PEARL Trial Results
Girish Harinath, Virginia Lee, Andy Nyquist, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3

The role of autophagy in the progression of HIV infected cardiomyopathy
Yuting Sun, Mengmeng Xu, Qinchun Duan, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 1

The bioavailability of compounded and generic rapamycin in normative aging individuals: A retrospective study and review with clinical implications
Girish Harinath, Virginia Lee, Andy Nyquist, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1

Sex-specific molecular signature of mouse podocytes in homeostasis and in response to pharmacological challenge with rapamycin
Ola Al-Diab, Christin Sünkel, Eric Blanc, et al.
Biology of Sex Differences (2024) Vol. 15, Iss. 1
Open Access

Suppressing the Aging Phenotype of Mesenchymal Stromal Cells: Are We Ready for Clinical Translation?
Ilaria Roato, Matteo Visca, Federico Mussano
Biomedicines (2024) Vol. 12, Iss. 12, pp. 2811-2811
Open Access

Page 1

Cookie	Duration	Description
cookielawinfo-checkbox-advertisement	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category .
cookielawinfo-checkbox-analytics	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Analytics" category .
cookielawinfo-checkbox-functional	1 year	The cookie is set by the GDPR Cookie Consent plugin to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Necessary" category .
cookielawinfo-checkbox-others	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to store the user consent for cookies in the category "Others".
cookielawinfo-checkbox-performance	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to store the user consent for cookies in the category "Performance".
CookieLawInfoConsent	1 year	Records the default button state of the corresponding category & the status of CCPA. It works only in coordination with the primary cookie.
PHPSESSID	session	This cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.

Requested Article:

Showing 15 citing articles:

Your Privacy